Scientists Develop Injectable HIV Drug with Fewer Side Effects
4 years, 4 months ago

Scientists Develop Injectable HIV Drug with Fewer Side Effects

News 18  

Researchers have developed an injectable new drug that blocks HIV from entering cells which offers long-lasting protection from the infection with fewer side effects. "It has great potential to help patients who suffer from drug resistance as well as those who would benefit from a longer-acting, injectable anti-HIV drug cocktail," Kay added. To see if CPT31 could prevent HIV infection, the research team first injected the drug into healthy macaque monkeys starting several days prior to exposure to a hybrid simian-human form of HIV called SHIV. "We think this drug could be used by itself to prevent HIV infection because initial HIV exposure typically involves a relatively small amount of virus," Kay said.

Drug Shiv Kay Hiv Infection Cpt31 Injectable Hiv  scientists  injectable  hiv  cpt31  study  researchers  fewer  develop  monkeys  prevent  team  drug  shiv  virus  effects

History of this topic

Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'
5 months ago

Experts say a twice-yearly injection that offers 100% protection against HIV is 'stunning'

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. The prospect of a twice-a-year …

Life-saving HIV drugs risk running out as COVID-19 hits supplies: WHO
4 years, 5 months ago

Life-saving HIV drugs risk running out as COVID-19 hits supplies: WHO

Live Mint  

More than a third of the world's countries say they are at risk of running out of life-saving AIDS drugs because of disruptions to supply lines and other problems caused by the COVID-19 pandemic, the World Health Organization said on Monday. "The findings of this survey are deeply concerning," the WHO's director general Tedros Adhanom Ghebreyesus said in a statement …

Discover Related